Welcome to Helix Talk, a podcast presented by the Rosalm Franklin University College of Pharmacy.

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics.

We're hoping that our real-life clinical pearls and discussions will help you stay up to date

and improve your pharmacy knowledge.

This is an educational production copyright Rosalind Franklin University of Medicine and Science.

This podcast contains general information for educational purposes only.

This is not professional advice and should not be used in lieu of obtaining advice from a qualified

health care provider.

And now, on to the show.

Welcome to Helix Talk, episode 13.

I'm your co-host, Dr. Kane. I'm Dr. Schumann. I'm your co-host Dr. Kane.

I'm Dr. Schumann.

I'm Dr. Hartranft.

And I'm Dr. Patel.

And we're very excited to have Dr. Hartranft with us today.

And we'll be talking about the American Heart Association and American College of Cardiology

2013 Obesity Guidelines, but focusing a lot on three FDA-approved medications for obesity

management.

So these guidelines were published along with the Disopidemia Management Guidelines back

in December last year.

And getting started, just a brief overview.

The screening recommendation obviously are making sure we are checking patients, heightened

...